Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.669
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2014English

Comparative Pharmacoeconomic Analysis of Rivaroxaban and Warfarin Usage in Patients With Non-Valvular Atrial Fibrillation

Jounal of arrhythmology
2020English

Practical Guide to Choosing Dabigatran 150 Mg Twice Daily or Apixaban 5 Mg Twice Daily for Patients With Atrial Fibrillation

Journal of Rural Medicine
2019English

How to Use Dabigatran in Patients With Atrial Fibrillation

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2012English

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2017English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data

Journal of managed care & specialty pharmacy
Health PolicyPharmacyPharmaceutical Science
2017English

Pcv42 - A Pharmacoeconomic Analysis of the Use of Apixaban for the Prevention of Stroke and Systemic Embolism in Russian Patients With Non-Valvular Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy